It could get interesting if RAC's preclinical for Melanoma evaluates Zantrene in combination with multiple PD-1 inhibitors as speculated by others here on HC before. Whilst a preclinical study is not a clinical trial the results could prove interesting. I wonder if RAC would try a number of PD-1s in their clinical trial - would require multiple arms in the trial.
From the above, the below is a comment by one of the top FDA Cancer Doctors in the New England Journal of medicine.
https://endpts.com/uncoordinated-an...nhibitor-developers-for-creating-a-wild-west/
![]()
The timing could be spectacularly perfect ... and I hope RAC make the most of it in terms of fine-tuning and discussing their plans.
![]()
- Forums
- ASX - By Stock
- RAC
- Industry news
Industry news, page-438
-
- There are more pages in this discussion • 1,331 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.86 |
Change
0.145(8.48%) |
Mkt cap ! $291.1M |
Open | High | Low | Value | Volume |
$1.85 | $1.96 | $1.77 | $474.7K | 250.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2732 | $1.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.86 | 477 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 1.820 |
1 | 2000 | 1.810 |
2 | 14277 | 1.800 |
1 | 4626 | 1.785 |
3 | 7500 | 1.780 |
Price($) | Vol. | No. |
---|---|---|
1.860 | 1000 | 1 |
1.870 | 1200 | 1 |
1.875 | 1500 | 1 |
1.900 | 1088 | 1 |
1.940 | 2061 | 1 |
Last trade - 10.30am 26/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |